Transdermal Drug Delivery Systems Market Size, Share & Trends Analysis Report By Technology (Electroporation, Iontophoresis, Ultrasound), By Application (Pain Management, CNS, Hormone), By Region, And Segment Forecasts, 2023 - 2030
Transdermal Drug Delivery System Market Growth & Trends
The global transdermal drug delivery system market is expected to reach USD 145.0 billion by 2030, registering a CAGR of 11.9% from 2023 to 2030, according to a new report by Grand View Research, Inc. Increasing adoption of transdermal patches, such as in the case of diabetes, which requires sustained and a daily dose of insulin is expected to provide the market with growth opportunities during the forecast period.
High demand for pain-free drug delivery is a major driving factor of the transdermal drug delivery systems market. In the case of diabetes, insulin has to be administered into the patient's body with the help of injections on a continuous basis. Continuous usage of injections to deliver insulin causes pain and increases the risk of transmission of chronic diseases, thus, making transdermal patches a better choice for delivering insulin in diabetic patients.
COVID-19 led to a significant fall in sales of transdermal drug delivery systems. This is because most of these drugs are prescribed drugs and the pandemic led to a sharp fall in patient visits to healthcare facilities. Factors such as lockdowns and travel restrictions led down by the government, to curb the spread of the virus, resulted in reduced patient visits. In addition, many individuals in order to avoid physical contact also avoided visiting healthcare facilities, as a precautionary measure.
However, with the world moving towards normalcy and various pharma companies focusing on developing new novel products, the market represents great opportunities for growth. Moreover, increasing investments by the government in R&D and healthcare are further accelerating the demand for transdermal drug delivery systems in the market.
Transdermal Drug Delivery System Market Report Highlights
- The iontophoresis segment dominated the market in 2022 owing to its efficacy in delivering drugs. The mechanical arrays segment is expected to maximum growth due to the increasing number of product launches
- The pain management segment accounted for the highest market share in 2022 due to increasing demand for transdermal patches used for pain management
- The cardiovascular segment is anticipated to experience maximum growth during the forecast period due to the increasing utilization of these systems in the treatment of cardiovascular diseases
- North America accounted for the highest market share in 2022 owing to a rise in investments by existing as well as new market players
- Increasing healthcare expenditure and huge investments in research and development represent lucrative growth opportunities in the Asia Pacific region
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Technology
- 1.1.2. Application
- 1.1.3. Regional scope
- 1.1.4. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR’s internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.3.5.1. Data for primary interviews in North America
- 1.3.5.2. Data for primary interviews in Europe
- 1.3.5.3. Data for primary interviews in Asia Pacific
- 1.3.5.4. Data for primary interviews in Latin America
- 1.3.5.5. Data for Primary interviews in MEA
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.2. Approach 1: Commodity flow approach
- 1.6.3. Volume price analysis (Model 2)
- 1.6.4. Approach 2: Volume price analysis
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
- 1.9.1. Objective 1
- 1.9.2. Objective 2
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Technology Outlook
- 2.2.2. Application Outlook
- 2.2.3. Regional Outlook
- 2.3. Competitive Insights
- Chapter 3. Transdermal Drug Delivery System Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Industry Value Chain Analysis
- 3.3.1. Reimbursement framework
- 3.4. Market Dynamics
- 3.4.1. Market driver analysis
- 3.4.1.1. Increasing Adoption of Transdermal Patches
- 3.4.1.2. Technological Advancements
- 3.4.1.3. High Demand for Pain Free Drug Delivery
- 3.4.2. Market restraint analysis
- 3.4.2.1. High Cost of Transdermal Technology
- 3.4.2.2. Limited Number of Approved Medications
- 3.5. Transdermal Drug Delivery System Market Analysis Tools
- 3.5.1. Industry Analysis - Porter’s
- 3.5.1.1. Supplier power
- 3.5.1.2. Buyer power
- 3.5.1.3. Substitution threat
- 3.5.1.4. Threat of new entrant
- 3.5.1.5. Competitive rivalry
- 3.5.2. PESTEL Analysis
- 3.5.2.1. Political landscape
- 3.5.2.2. Technological landscape
- 3.5.2.3. Economic landscape
- 3.5.3. Major Deals & Strategic Alliances Analysis
- 3.5.4. Market Entry Strategies
- Chapter 4. Transdermal Drug Delivery System Device: Technology Estimates & Trend Analysis
- 4.1. Definitions and Scope
- 4.1.1. Electroporation
- 4.1.2. Radio Frequency
- 4.1.3. Iontophoresis
- 4.1.4. Microporation
- 4.1.5. Thermal
- 4.1.6. Mechanical arrays
- 4.1.7. Ultrasound
- 4.1.8. Others
- 4.2. Technology Market Share, 2022& 2030
- 4.3. Segment Dashboard
- 4.4. Global Transdermal Drug Delivery System Market by Technology Outlook
- 4.5. Market Application& Forecasts and Trend Analyses, 2018 to 2030 for the following
- 4.5.1. Electroporation
- 4.5.1.1. Market estimates and forecast 2018 - 2030 (Revenue in USD Million)
- 4.5.2. Radio Frequency
- 4.5.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 4.5.3. Iontophoresis
- 4.5.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 4.5.4. Microporation
- 4.5.4.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 4.5.5. Thermal
- 4.5.5.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 4.5.6. Mechanical Arrays
- 4.5.6.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 4.5.7. Ultrasound
- 4.5.7.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 4.5.8. Others
- 4.5.8.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- Chapter 5. Transdermal Drug Delivery System: Application Estimates & Trend Analysis
- 5.1. Definitions and Scope
- 5.1.1. CNS
- 5.1.2. Pain Management
- 5.1.3. Cardiovascular
- 5.1.4. Hormone
- 5.1.5. Immunological
- 5.1.6. Metabolic
- 5.1.7. Gastrointestinal
- 5.1.8. Infection
- 5.1.9. Cancer
- 5.1.10. Others
- 5.2. Application Market Share, 2022& 2030
- 5.3. Segment Dashboard
- 5.4. Global Transdermal Drug Delivery System Market by Application Outlook
- 5.5. Market Application& Forecasts and Trend Analyses, 2018 to 2030 for the following
- 5.5.1. CNS
- 5.5.1.1. Market estimates and forecast, 2018 - 2030(Revenue in USD Million)
- 5.5.2. Pain Management
- 5.5.2.1. Market estimates and forecast, 2018 - 2030(Revenue in USD Million)
- 5.5.3. Cardiovascular
- 5.5.3.1. Market estimates and forecast, 2018 - 2030(Revenue in USD Million)
- 5.5.4. Hormone
- 5.5.4.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 5.5.5. Immunological
- 5.5.5.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 5.5.6. Metabolic
- 5.5.6.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 5.5.7. Gastrointestinal
- 5.5.7.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 5.5.8. Infection
- 5.5.8.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 5.5.9. Cancer
- 5.5.9.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 5.5.10. Others
- 5.5.10.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 5.5.10.2. Urological
- 5.5.10.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 5.5.10.3. Blood Disorders
- 5.5.10.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 5.5.10.4. Respiratory
- 5.5.10.4.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 5.5.10.5. Musculoskeletal
- 5.5.10.5.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- Chapter 6. Market: Regional Estimates & Trend Analysis
- 6.1. Regional market share analysis, 2022& 2030
- 6.2. Regional Market Dashboard
- 6.3. Global Regional Market Snapshot
- 6.4. Regional Market Share and Leading Players, 2022
- 6.4.1. North America
- 6.4.2. Europe
- 6.4.3. Asia Pacific
- 6.4.4. Latin America
- 6.4.5. Middle East and Africa
- 6.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
- 6.5.1. North America
- 6.5.2. Europe
- 6.5.3. Asia Pacific
- 6.5.4. Latin America
- 6.5.5. Middle East and Africa
- 6.6. Market Application, & Forecasts and Trend Analysis, 2018 to 2030:
- 6.7. North America
- 6.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 6.7.2. U.S.
- 6.7.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 6.7.3. Canada
- 6.7.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 6.8. Europe
- 6.8.1. U.K.
- 6.8.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 6.8.2. Germany
- 6.8.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 6.8.3. France
- 6.8.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 6.8.4. Italy
- 6.8.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 6.8.5. Spain
- 6.8.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 6.8.6. Denmark
- 6.8.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 6.8.7. Sweden
- 6.8.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 6.8.8. Norway
- 6.8.8.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 6.9. Asia Pacific
- 6.9.1. Japan
- 6.9.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 6.9.2. India
- 6.9.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 6.9.3. China
- 6.9.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 6.9.4. South Korea
- 6.9.4.1 Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 6.9.5. Thailand
- 6.9.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 6.9.6. Australia
- 6.9.6.1 Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 6.10. Latin America
- 6.10.1. Brazil
- 6.10.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 6.10.2. Mexico
- 6.10.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 6.10.3. Argentina
- 6.10.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 6.11. MEA
- 6.11.1. South Africa
- 6.11.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 6.11.2. Saudi Arabia
- 6.11.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 6.11.3. UAE
- 6.11.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 6.11.4. Kuwait
- 6.11.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis, By Key Market Participants
- 7.2. Company/Competition Categorization
- 7.2.1. Innovators
- 7.2.2. Market Leaders
- 7.2.3. Emerging Players
- 7.3. Vendor Landscape
- 7.3.1. List of key distributors and channel partners
- 7.3.2. Key customers
- 7.3.3. Key company market share analysis, 2022
- 7.3.4. Novartis AG
- 7.3.4.1. Company overview
- 7.3.4.2. Financial performance
- 7.3.4.3. Product benchmarking
- 7.3.4.4. Strategic initiatives
- 7.3.5. Johnson & Johnson
- 7.3.5.1. Company overview
- 7.3.5.2. Financial performance
- 7.3.5.3. Product benchmarking
- 7.3.5.4. Strategic initiatives
- 7.3.6. Mylan Pharmaceuticals, Inc.
- 7.3.6.1. Company overview
- 7.3.6.2. Financial performance
- 7.3.6.3. Product benchmarking
- 7.3.6.4. Strategic initiatives
- 7.3.7. Boehringer Ingelheim GmbH Overview
- 7.3.7.1. Financial performance
- 7.3.7.2. Product benchmarking
- 7.3.7.3. Strategic initiatives
- 7.3.8. Biogel Technology, Inc.
- 7.3.8.1. Company overview
- 7.3.8.2. Financial performance
- 7.3.8.3. Product benchmarking
- 7.3.8.4. Strategic initiatives
- 7.3.9. Transdermal Technologies, Inc.
- 7.3.9.1. Company overview
- 7.3.9.2. Financial performance
- 7.3.9.3. Product benchmarking
- 7.3.9.4. Strategic initiatives
- 7.3.10. Skyepharma
- 7.3.10.1. Company overview
- 7.3.10.2. Financial performance
- 7.3.10.3. Product benchmarking
- 7.3.10.4. Strategic initiatives
- 7.3.11. Watson Pharmaceuticals, Inc.
- 7.3.11.1. Company overview
- 7.3.11.2. Financial performance
- 7.3.11.3. Product benchmarking
- 7.3.11.4. Strategic initiatives
- 7.3.12. 3M Company
- 7.3.12.1. Company overview
- 7.3.12.2. Financial performance
- 7.3.12.3. Product benchmarking
- 7.3.12.4. Strategic initiatives
- 7.3.13. Noven Pharmaceuticals, Inc.
- 7.3.13.1. Company overview
- 7.3.13.2. Financial performance
- 7.3.13.3. Product benchmarking
- 7.3.13.4. Strategic initiatives
- 7.3.14. 4P Therapeutics, LLC
- 7.3.14.1. Company overview
- 7.3.14.2. Financial performance
- 7.3.14.3. Product benchmarking
- 7.3.14.4. Strategic initiatives
- 7.3.15. Transdermal Corporation
- 7.3.15.1. Company overview
- 7.3.15.2. Financial performance
- 7.3.15.3. Product benchmarking
- 7.3.15.4. Strategic initiatives
- 7.3.16. Echo Therapeutics, Inc.
- 7.3.16.1. Company overview
- 7.3.16.2. Financial performance
- 7.3.16.3. Product benchmarking
- 7.3.16.4. Strategic initiatives
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook